227 related articles for article (PubMed ID: 35283317)
21. Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis.
Ding ZN; Meng GX; Xue JS; Yan LJ; Liu H; Yan YC; Chen ZQ; Hong JG; Wang DX; Dong ZR; Li T
J Cancer Res Clin Oncol; 2023 May; 149(5):1993-2008. PubMed ID: 35767193
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
[TBL] [Abstract][Full Text] [Related]
23. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).
Drgona L; Gudiol C; Lanini S; Salzberger B; Ippolito G; Mikulska M
Clin Microbiol Infect; 2018 Jun; 24 Suppl 2():S83-S94. PubMed ID: 29572070
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection.
Jacob R; Danta M
Expert Opin Pharmacother; 2022 Mar; 23(4):465-472. PubMed ID: 34937470
[TBL] [Abstract][Full Text] [Related]
25. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis.
Li L; Jiang X; Fu L; Zhang L; Feng Y
Clin Exp Med; 2023 Jul; 23(3):701-715. PubMed ID: 35499793
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection.
Wahle RC; Perez RM; Pereira PF; Oliveira EM; Emori CT; Uehara SN; Silva IS; Silva AE; Ferraz ML
Braz J Infect Dis; 2015; 19(5):533-7. PubMed ID: 25997784
[TBL] [Abstract][Full Text] [Related]
27. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
28. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy.
Hakim MS; Rahmadika N; Jariah ROA
Rev Med Virol; 2020 Mar; 30(2):e2094. PubMed ID: 31825155
[TBL] [Abstract][Full Text] [Related]
29. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
[TBL] [Abstract][Full Text] [Related]
30. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature.
Snast I; Atzmony L; Braun M; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Jul; 77(1):88-97.e5. PubMed ID: 28495497
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
Yazici O; Sendur MA; Aksoy S
World J Gastroenterol; 2014 Jun; 20(22):6716-24. PubMed ID: 24944464
[TBL] [Abstract][Full Text] [Related]
32. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
[TBL] [Abstract][Full Text] [Related]
33. Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Hong J; Lee J; Park S; Jung HA; Sun JM; Lee SH; Ahn JS; Sinn DH; Ahn MJ
Cancer; 2024 May; 130(9):1693-1701. PubMed ID: 38165808
[TBL] [Abstract][Full Text] [Related]
34. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
Yeh ML; Huang CF; Hsieh MH; Ko YM; Chen KY; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CI; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
J Gastroenterol Hepatol; 2017 Oct; 32(10):1754-1762. PubMed ID: 28230928
[TBL] [Abstract][Full Text] [Related]
35. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen.
Londoño MC; Lens S; Mariño Z; Bonacci M; Ariza X; Broquetas T; Pla A; Bartres C; Adriani MV; Rodríguez-Tajes S; Costa J; Carrión JA; Pérez-Del-Pulgar S; Forns X
Aliment Pharmacol Ther; 2017 Apr; 45(8):1156-1161. PubMed ID: 28206681
[TBL] [Abstract][Full Text] [Related]
37. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Ogawa E; Furusyo N; Murata M; Toyoda K; Hayashi T; Ura K
Liver Int; 2018 Jan; 38(1):76-83. PubMed ID: 28618152
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
Juan J; Feld JJ
Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
[TBL] [Abstract][Full Text] [Related]
39. Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.
Kyriakidis I; Vasileiou E; Rossig C; Roilides E; Groll AH; Tragiannidis A
J Fungi (Basel); 2021 Mar; 7(3):. PubMed ID: 33807678
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B surface antibody titres and hepatitis B reactivation with direct-acting antiviral therapy for hepatitis C.
Poola S; Sanaka S; Sewell K; Tillmann HL
J Viral Hepat; 2021 Feb; 28(2):373-382. PubMed ID: 33047433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]